Teva Pharma Stock Forward View - Accumulation Distribution

TEVA Stock  USD 33.98  0.06  0.18%   
Teva Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Teva Pharma stock prices and determine the direction of Teva Pharma Industries's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Teva Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the relative strength index (rsi) of Teva Pharma's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Teva Pharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Teva Pharma Industries, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Teva Pharma's stock price prediction:
Quarterly Earnings Growth
0.4
EPS Estimate Next Quarter
0.5979
EPS Estimate Current Year
2.6817
EPS Estimate Next Year
3.0889
Wall Street Target Price
37.5909
Using Teva Pharma hype-based prediction, you can estimate the value of Teva Pharma Industries from the perspective of Teva Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Teva Pharma using Teva Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Teva using crowd psychology based on the activity and movement of Teva Pharma's stock price.

Teva Pharma Short Interest

A significant increase or decrease in Teva Pharma's short interest from the previous month could be a good indicator of investor sentiment towards Teva. Short interest can provide insight into the potential direction of Teva Pharma stock and how bullish or bearish investors feel about the market overall.
200 Day MA
22.0475
Short Percent
0.0332
Short Ratio
3.61
Shares Short Prior Month
32.9 M
50 Day MA
31.8868

Teva Relative Strength Index

Teva Pharma Industries Hype to Price Pattern

Investor biases related to Teva Pharma's public news can be used to forecast risks associated with an investment in Teva. The trend in average sentiment can be used to explain how an investor holding Teva can time the market purely based on public headlines and social activities around Teva Pharma Industries. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Teva Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Teva Pharma.

Teva Pharma Implied Volatility

    
  0.59  
Teva Pharma's implied volatility exposes the market's sentiment of Teva Pharma Industries stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Teva Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Teva Pharma stock will not fluctuate a lot when Teva Pharma's options are near their expiration.

Teva Pharma after-hype prediction price

    
  USD 33.93  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Teva Pharma to cross-verify your projections.

Prediction based on Rule 16 of the current Teva contract

Based on the Rule 16, the options market is currently suggesting that Teva Pharma Industries will have an average daily up or down price movement of about 0.0369% per day over the life of the 2026-04-02 option contract. With Teva Pharma trading at USD 33.98, that is roughly USD 0.0125 . If you think that the market is fully incorporating Teva Pharma's daily price movement you should consider acquiring Teva Pharma Industries options at the current volatility level of 0.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-04-02 Teva Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Teva Pharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Teva Pharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Teva Pharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Teva Pharma's open interest, investors have to compare it to Teva Pharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Teva Pharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Teva. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Teva Pharma Additional Predictive Modules

Most predictive techniques to examine Teva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Teva using various technical indicators. When you analyze Teva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Teva Pharma Industries has current Accumulation Distribution of 0.0161. The accumulation distribution (A/D) indicator shows the degree to which Teva Pharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Teva Pharma Industries to determine if accumulation or reduction is taking place in the market. This value is adjusted by Teva Pharma trading volume to give more weight to distributions with higher volume over lower volume.
Check Teva Pharma VolatilityBacktest Teva PharmaInformation Ratio  

Teva Pharma Trading Date Momentum

On February 15 2026 Teva Pharma Industries was traded for  33.98  at the closing time. The top price for the day was 34.25  and the lowest listed price was  33.70 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.18% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Teva Pharma to competition

Other Forecasting Options for Teva Pharma

For every potential investor in Teva, whether a beginner or expert, Teva Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Teva Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Teva. Basic forecasting techniques help filter out the noise by identifying Teva Pharma's price trends.

Teva Pharma Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Teva Pharma Market Strength Events

Market strength indicators help investors to evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Teva Pharma shares will generate the highest return on investment. By undertsting and applying Teva Pharma stock market strength indicators, traders can identify Teva Pharma Industries entry and exit signals to maximize returns.

Teva Pharma Risk Indicators

The analysis of Teva Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Teva Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting teva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Teva Pharma

The number of cover stories for Teva Pharma depends on current market conditions and Teva Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Teva Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Teva Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Teva Pharma Short Properties

Teva Pharma's future price predictability will typically decrease when Teva Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Teva Pharma Industries often depends not only on the future outlook of the potential Teva Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.2 B
Cash And Short Term Investments3.6 B
When determining whether Teva Pharma Industries offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teva Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teva Pharma Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teva Pharma Industries Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Teva Pharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
0.4
Earnings Share
1.21
Revenue Per Share
15.072
Quarterly Revenue Growth
0.114
Return On Assets
0.0617
Understanding Teva Pharma Industries requires distinguishing between market price and book value, where the latter reflects Teva's accounting equity. The concept of intrinsic value - what Teva Pharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Teva Pharma's price substantially above or below its fundamental value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Teva Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.